Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K024189
    Manufacturer
    Date Cleared
    2003-06-20

    (183 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    NLITE SYSTEM, MODEL#: A00-1025/A00-1033

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The NLite System is indicated for use in the specialties of Dermatology and Plastic Surgery, and in particular for the treatment of Inflammatory Acne Vulgaris`.
    The NLite System is indicated for use in Dermatological and Plastic Surgery applications and this device is intended for use in the treatment of Inflammatory Acne Vulgaris.

    Device Description

    The NLite System is a flashlamp pumped, pulsed dye laser consisting of the following:

    • Main laser console incorporating the laser resonator and external optics, high . voltage delivery system, internal cooler, fluid circulation system, control unit and user interface;
    • Flexible fibre optic delivery device and optical handpiece; ●
    • Footswitch for pulsing control. ●
    AI/ML Overview

    The provided text for the K024189 submission about the ICN Photonics NLite System does not contain the detailed information necessary to fully address all aspects of the request regarding acceptance criteria and the study proving the device meets them. The submission primarily focuses on establishing substantial equivalence to a predicate device and confirming safety and efficacy for its stated indications for use (treatment of Inflammatory Acne Vulgaris).

    Here's a breakdown of what can and cannot be extracted from the provided documents:

    1. A table of acceptance criteria and the reported device performance

    The document does not explicitly state quantitative acceptance criteria (e.g., a specific percentage reduction in lesions, or a particular success rate) or present a table of device performance against such criteria. It generally states that "Clinical data has been provided to demonstrate that the NLite system is safe and effective for the described indications for use" and "The clinical data provided has demonstrated that the specific indications for use is met and the safety and efficacy of the system has been proved."

    2. Sample sized used for the test set and the data provenance

    This information is not provided in the submission. There is no mention of the number of subjects in any clinical study.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not provided in the submission.

    4. Adjudication method for the test set

    This information is not provided in the submission.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    The NLite System is a laser-based medical device for treating acne, not an AI-assisted diagnostic or imaging device. Therefore, a multi-reader multi-case (MRMC) comparative effectiveness study with AI assistance is not applicable and not mentioned.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This question is not applicable as the NLite System is a therapeutic device, not an algorithm, and intrinsically involves human-in-the-loop operation (a practitioner using the laser).

    7. The type of ground truth used

    While not explicitly stated as "ground truth," the studies for demonstrating safety and efficacy for a therapeutic device like this would typically rely on clinical outcomes data. This would involve pre- and post-treatment assessment of acne severity (e.g., lesion counts, grading scales), patient satisfaction, and adverse event reporting.

    8. The sample size for the training set

    This information is not provided. For a therapeutic device, there isn't a "training set" in the machine learning sense. The clinical studies (which would serve as the basis for evidence) are referred to globally without specific numbers.

    9. How the ground truth for the training set was established

    As with point 8, the concept of a "training set" with established ground truth in the machine learning context does not directly apply to this type of device. The evidence for efficacy would be established through a clinical trial where clinical endpoints (e.g., reduction in acne lesions) are measured and assessed by clinicians.


    Summary of available information as per the request:

    FeatureReported Information / Status
    Acceptance CriteriaNot explicitly stated in quantitative terms. The general criterion for approval appears to be "safe and effective for the described indications for use" and that "the specific indications for use is met."
    Reported Device Performance"Clinical data has been provided to demonstrate that the NLite system is safe and effective." Specific performance metrics (e.g., percentage improvement in acne, side effect rates) are not detailed in this summary document.
    Test Set Sample SizeNot provided.
    Test Set Data ProvenanceNot provided (e.g., country of origin, retrospective/prospective).
    Number of Experts for GTNot provided.
    Qualifications of Experts for GTNot provided.
    Adjudication MethodNot applicable/Not provided.
    MRMC Comparative Effectiveness StudyNot applicable (device is a laser for treatment, not an AI diagnostic aid).
    Effect Size of Human Improvement with AINot applicable.
    Standalone Performance Study (Algorithm only)Not applicable (device is a physical laser system, not an algorithm).
    Type of Ground Truth UsedClinical outcomes data (e.g., assessment of acne severity, lesion counts, patient response, adverse event rates from clinical studies).
    Training Set Sample SizeNot applicable in the ML sense; clinical study sample size not provided.
    How Training Set GT was establishedNot applicable in the ML sense. Efficacy evidence would be established through clinical assessment of treatment outcomes by qualified healthcare professionals during a clinical study.

    In conclusion, this 510(k) submission summary for the NLite System focuses on demonstrating substantial equivalence to a predicate device and confirming general safety and effectiveness through clinical data, rather than providing the detailed technical and statistical information typically found for AI/ML-based diagnostic devices. The details requested are not present in this regulatory document.

    Ask a Question

    Ask a specific question about this device

    K Number
    K013461
    Manufacturer
    Date Cleared
    2002-01-17

    (91 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    NLITE SYSTEM,MODEL A00-1025

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The NLite System is indicated for use in the specialties of Dermatology and Plastic Surgery, and in particular for the treatment of wrinkles.

    The NLite System is indicated for use in Dermatological and Plastic Surgery applications and this device is intended for use in the treatment of wrinkles.

    Device Description

    The NLite System is a flashlamp pumped, pulsed dye laser consisting of the following:

    • Main laser console incorporating the laser resonator and external optics, high voltage delivery system, internal cooler, fluid circulation system, control unit and user interface;
    • Flexible fibre optic delivery device and optical handpiece;
    • Footswitch for pulsing control.
    AI/ML Overview

    The provided text details a 510(k) submission for the ICN Photonics NLite System, specifically for an expansion of its claims to include the treatment of wrinkles. However, it does not contain the detailed acceptance criteria for a study, nor the reported device performance against such criteria. The document is primarily a regulatory submission for substantial equivalence.

    Therefore, I cannot fulfill the request to describe the acceptance criteria and the study that proves the device meets them with the provided input. The document mentions that "Clinical data has been provided to demonstrate that the NLite system is safe and effective for the described indications for use," and "The clinical data provided has demonstrated that the specific indications for use is met and the safety and efficacy of the system has been proved," but it does not include the details of this clinical data.

    To answer your request, information on the specific study design, acceptance criteria, and detailed results would be needed.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1